This list is based on the watchlists of people on Stock Events who follow TA50.STU. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Circio Holding ASA, a biotechnology company, develops novel circular RNA and immunotherapy medicines. The company is developing TG01, a cancer vaccine targeting driver mutations, which is in three clinical trials for multiple myeloma, and pancreatic and lung cancer; and circVec circRNA vector platform, a modular genetic cassette for biogenesis of multifunctional circRNAs in human cells. It has a collaboration with Certest Biotec, S.L. for formulation of circVec. The company has a research collaboration with United Immunity Co., Ltd. for the development of vivo CAR-Macrophage (CAR-M) therapy. The company was formerly known as Targovax ASA and changed its name to Circio Holding ASA in May 2023. The company was incorporated in 2010 and is based in Oslo, Norway.
The current price of TA50.STU is €1.06 EUR — it has decreased by -0.19% in the past 24 hours. Watch Circio ASA stock price performance more closely on the chart.
What is Circio ASA stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Circio ASA stocks are traded under the ticker TA50.STU.
Is Circio ASA stock price growing?▼
TA50.STU stock has risen by +17.17% compared to the previous week, the month change is a +271.23% rise, over the last year Circio ASA has showed a +2,814.6% increase.
How many employees does Circio ASA have?▼
As of April 10, 2026, the company has 9 employees.